Your browser doesn't support javascript.
loading
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt, Jonathan; Lafayette, Richard; Kristensen, Jens; Stone, Andrew; Cattran, Daniel; Floege, Jürgen; Tesar, Vladimir; Trimarchi, Hernán; Zhang, Hong; Eren, Necmi; Paliege, Alexander; Rovin, Brad H.
Afiliación
  • Barratt J; College of Medicine Biological Sciences and Psychology, University of Leicester, Leicester, UK.
  • Lafayette R; Division of Nephrology, Department of Medicine, Stanford University, Stanford, California, USA.
  • Kristensen J; Calliditas Therapeutics AB, Stockholm, Sweden.
  • Stone A; Stone Biostatistics Ltd., Crewe, UK.
  • Cattran D; Division of Nephrology, Toronto General Hospital Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Floege J; Department of Nephrology and Clinical Immunology, Rheinisch Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany.
  • Tesar V; Department of Nephrology, 1st School of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
  • Trimarchi H; Nephrology Service, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
  • Zhang H; Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
  • Eren N; Department of Nephrology, Kocaeli University, Kocaeli, Turkey.
  • Paliege A; Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
  • Rovin BH; Division of Nephrology, the Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Electronic address: Brad.Rovin@osumc.edu.
Kidney Int ; 103(2): 391-402, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36270561
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Budesonida / Glomerulonefritis por IGA Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Kidney Int Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Budesonida / Glomerulonefritis por IGA Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Kidney Int Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido